Cover Image

2012 Germany Tumor Marker Testing Market Outlook: Growth Opportunities and Strategies

Notice
This publication has been discontinued on July 23, 2012.

Abstract

Highlights

  • Comprehensive 585-page analysis of the German tumor marker testing market.
  • Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Ten-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains: 585 pages and 95 tables.

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Cancer Statistics and Etiology
    • 1. Brest Cancer
    • 2. Lung Cancer
    • 3. Colon and Rectum Cancer
    • 4. Prostate Cancer
    • 5. Stomach Cancer
    • 6. Leukemia
    • 7. Lymphoma
    • 8. Oral Cancer
    • 9. Skin Cancer
    • 10. Uterine Cancer
    • 11. Ovarian Cancer
    • 12. Bladder Cancer
  • B. Major Current And Emerging Cancer Diagnostic Tests
    • 1. Introduction
    • 2. Tumor Marker Classification
    • 3. ACTH
    • 4. Alpha-Fetoprotein (AFP)
    • 5. Beta-2 Microglobulin
    • 6. CA 15-3/27.29
    • 7. CA 19-9
    • 8. CA-125
    • 9. Calcitonin
    • 10. Carcinoembrionic Antigen (CEA)
    • 11. Estrogen and Progesterone Receptors
    • 12. Ferritin
    • 13. Gastrin
    • 14. Human Chorionic Gonadotropin (HCG)
    • 15. Insulin
    • 16. NSE
    • 17. Occult Blood
    • 18. PAP Smear/HPV
    • 19. Prostatic Acid Phosphatase (PAP)
    • 20. Prostate-Specific Antigen (PSA)
    • 21. Squamous Cell Carcinoma Antigen (SCC)
    • 22. T and B Lymphocytes
    • 23. TdT
    • 24. Thyroglobulin
    • 25. Tissue Polypeptide Antigen (TPA)
    • 26. Biochemical Tumor Markers
      • ADA
      • B-Protein
      • PNP
      • 5'-Nucleotidase
    • 27. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP-17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
    • 28. Polypeptide Growth Factors
      • Basic Fibroblast Growth Factor
        • Beta-TGF
        • Cachectin (TNT)
        • Calmodulin
        • ECFR
        • Nerve Growth Factor (NGF)
        • Epidermal Growth Factor (EGF)
        • Ornithine Decarboxylase
        • Transferrin
        • Transforming Growth Factor-Alpha
    • 29. Ectopic Hormones
    • 30. Colony Stimulating Factors
    • 31. Lymphokines
      • Alpha-Interferon
      • B Cell Growth Factors
      • B Cell Growth Factor (BCGF)
      • Gamma-Interferon
      • Interleukin-1 (IL-1)
      • Macrophage Activating Factor
    • 32. Immunohistochemical Stains
    • 33. Emerging Tumor Markers
      • N-Acetylglucosamine
      • Actin
      • Alpha-Actin
      • Antineuronal Antibodies
      • 7B2
      • B72.3
      • Bax
      • BCD-F9
      • BLCA-4
      • Blood Group Antigens A,B,H
      • CA 50
      • CA 72-4/TAG-72
      • CA 195
      • CA-242
      • CA-549
      • CAM 26
      • CAR-3
      • Cathepsin-D
      • Chromogranin A and B
      • Cluster 1 Antigen
      • Cluster-5/5A Antigen
      • CTA
      • CU18
      • DR-70
      • DU-PAN-2
      • Endometrial Bleeding Associated Factor
      • Endostatin
      • Epithelial Membrane Antigen
      • Feulgen Hydrolysis
      • Fibronectin
      • FSH
      • (1->3)-L-fucosyltransferase
      • Gastrin-Releasing Peptide (GRP)
      • GDCFP-15
      • Glucagon
      • Glycoamines
      • H23
      • Her-2
      • Human Carcinoma Antigen
      • HPA
      • HSP27
      • Intermediate Filaments
      • Cytokeratins/CK18/Cyfra 21-1
      • Desmin
      • Gliofibrillary Acid Protein
      • Neurofilaments
      • Vimentin
      • KA 93
      • Kinases
      • KP16D3
      • LAI
      • Leukocyte Common Antigen
      • Lewis Antigens
      • Lysophosphatidic Acid (LPA)
      • Ma 695/Ma 552
      • MABDF3
      • MAG
      • ME1
      • Minactivin
      • MN/CA9
      • MSA
      • Mucin Cancer Antigen (MCA)
      • Multiple Tumor Suppressor 1
      • Myosin
      • NEA-130
      • NMP22
      • OA-519
      • Opiod Peptides
      • P-glycoprotein
      • Pancreatic Oncofetal Antigen (POA)
      • Placental Lactogen
      • PR92
      • Proliferative Index, Ki-67
      • Px
      • RB Inactivation/Deletion
      • Ret
      • SCCL 175
      • Selectin
      • Sialic Acid
      • Sialyl SSEA-1/SLX
      • SN10
      • Somatostatin
      • TA-90
      • TABA
      • Tachykinin
      • TAG 12
      • TPS
      • Troponin
      • Tubulin
      • VCAM
      • VEGF
      • Villen
      • C. Instrumentation Review And Market Needs
    • 1. Abbott AxSYM
    • 2. Abbott Architect c4000
    • 3. Abbott Architect i2000 Series
    • 4. Abbott Architect ci8200 System
    • 5. Beckman Coulter UniCel Series
    • 6. Beckman Coulter Access
    • 7. Binding Site ESP600
    • 8. bioMerieux Mini Vidas
    • 9. Carolina Chemistries BioLis 24i
    • 10. DiaSorin Liaison
    • 11. Horiba ABX Pentra 400
    • 12. Inverness DS2
    • 13. J&J Vitros ECi/ECiQ
    • 14. J&J Vitros 3600
    • 15. J&J Vitros 5600
    • 16. Olympus AU5400
    • 17. Olympus AU3000i
    • 18. Olympus AU2700
    • 19. Roche Modular Analytics
    • 20. Roche Cobas Integra 400
    • 21. Roche Cobas Integra 400 Plus
    • 22. Roche Elecsys
    • 23. Roche Cobas c311
    • 24. Siemens ADVIA Centaur
    • 25. Siemens Dimension
    • 26. Siemens Dimension RxL Max
    • 27. Siemens Dimension Vista 500
    • 28. Siemens Immulite
    • 29. Siemens Stratus
    • 30. Tosoh AIA-Series
    • 31. Vital Diagnostics ATAC 8000
    • 32. Vital Diagnostics Envoy 500
  • D. Current and Emerging Technologies
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • b. Radioimmunoassay (RIA)
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • Immunofiltration
        • Particle-Membrane Capture Immunoassay
        • Enzyme Amplification
      • d. Fluorescent Immunoassays
      • e. Luminescence
        • Chemiluminescence
        • Bioluminescence
      • f. Latex Agglutination
      • g. Immunoprecipitation
        • H. Affinity Chromatographu
        • e. Liposome Flow-Injection Immunoassay
    • 3. Molecular Diagnostics
      • a. Technology Overview
      • b. Amplification Methods
        • PCR
        • DAP-PCR
        • Immuno-PCR
        • QC-PCR
        • CAR
        • DNA
        • HPA
        • LCR
        • NASBA
        • QBR
        • SDA
        • 3 SR, and others
    • 4. Chromosome Analysis
      • a. Chronic Myelogenous Leukemia (CML)
      • b. Acute Myeloid Leukemia (AML)
      • c. Acute Lymphoblastic Leukemia (ALL)
      • d. Malignant Lymphomas
        • Lymphoid Malignancies
      • e. Chronic Lymphocytic Leukemia (CLL)
      • f. Solid Cancers
      • g. Chromosomal Translocation and Oncogenes
    • 5. Artificial Intelligence
    • 6. Flow Cytometry
    • 7. Two Dimensional Gel Electrophoresis (2-DGE)
    • 8. Biosensors
    • 9. Competing/Complementing Technologies
      • a. CT
      • b. MRI
      • c. NMR
      • d. PET
      • e. Photonics Spectroscopy
  • E. Personal Testing

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Otho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

Appendixes

  • Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications
  • Appendix II: Assumed Currency Exchange Rates

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume nd Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by MarketSegment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market egment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Mar Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics
Show More
Pricing
Not Available